Presents the latest findings on the effects of pneumococcal conjugate vaccine.
- Describes the development of the vaccines, their remarkable impact on respiratory and other pneumococcal infections, and the vaccines’ wider impact on public health.
- Includes chapters on epidemiology, immunologic mechanisms, conjugation methods, antibiotic resistance, PCV immunogenicity in healthy and high-risk individuals, otitis media, and direct and indirect protective effects.
- Summarizes the current knowledge on pneumococcal vaccines with particular emphasis on the years after the introduction of the conjugate vaccine for professionals in academia, public health, government, or industry.